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Abstract
Objectives: To analyze how graft-weight-to-body-
weight ratio in pediatric liver transplant affects
intraoperative and early postoperative hemodynamic
and metabolic parameters. 
Materials and Methods: We reviewed data from 130
children who underwent liver transplant between
2005 and 2015. Recipients were divided into 2 groups:
those with a graft weight to body weight ratio > 4%
(large for size) and those with a ratio ≤ 4% (normal for
size). Data included demographics, preoperative
laboratory findings, intraoperative metabolic and
hemodynamic parameters, and intensive care follow-
up parameters. 
Results: Patients in the large-graft-for-size group (> 4%)
received more colloid solution (57.7 ± 20.1 mL/kg 
vs 45.1 ± 21.9 mL/kg; P = .08) and higher doses of
furosemide (0.7 ± 0.6 mg/kg vs 0.4 ± 0.7 mg/kg; 
P = .018). They had lower mean pH (7.1 ± 0.1 vs 
7.2 ± 0.1; P = .004) and PO2 (115.4 ± 44.6 mm Hg 
vs 147.6 ± 49.3 mm Hg; P = .004) values, higher 
blood glucose values (352.8 ± 96.9 mg/dL vs 
262.8 ± 88.2 mg/dL; P < .001), and lower mean body
temperature (34.8 ± 0.7°C vs 35.2 ± 0.6°C; P = .016)
during the neohepatic phase. They received more
blood transfusions during both the anhepatic 
(30.3 ± 24.3 mL/kg vs 18.8 ± 21.8 mL/kg; P = .013) and
neohepatic (17.7 ± 20.4 mL/kg vs 10.3 ± 15.5 mL/kg; 
P = .031) phases and more fresh frozen plasma 
(13.6 ± 17.6 mL/kg vs 6.2 ± 10.2 mL/kg; P= .012) during
the neohepatic phase. They also were more likely to be
hypotensive (P < .05) and to receive norepinephrine
infusion more often (44% vs 22%; P < .05) intra -
operatively. More patients in this group were
mechanically ventilated in the intensive care unit (56%
vs 31%; P = .035). There were no significant differences
between the groups in postoperative acute renal
dysfunction, graft rejection or loss, infections, length
of intensive care stay, and mortality (P > .05). 
Conclusions: High graft weight-to-body-weight ratio is
associated with adverse metabolic and hemodynamic
changes during the intraoperative and early pos -
toperative periods. These results emphasize the
importance of using an appropriately sized graft in
liver transplant. 
Key words: Hemodynamic changes, Large graft for
size, Metabolic changes, Normal graft for size, Pediatric
patients
Introduction
Liver transplant for acute or chronic liver failure in
pediatric patients is becoming more common.1
Advances in surgical techniques, immuno sup -
pressive therapy, and postoperative intensive care
are resulting in increased success rates in these
patients.2,3 However, there also are increased
complications in pediatric liver transplant patients
compared to adult liver transplant patients,
particularly related to vascular thrombosis-asso -
ciated graft loss.1,2
There are 3 graft types used in pediatric patients:
(1) whole organ deceased-donor transplant, (2)
deceased-donor split liver transplant, and (3) living-
donor liver transplant.2 A mismatch in graft size
versus patient size is a rare but critical issue in living-
donor liver transplant.4 Small-for-size grafts are
associated with poor graft survival. Postoperative
graft dysfunction caused by a graft that is
insufficiently sized to maintain adequate liver
function presents as cholestasis, coagulopathy, portal
hypertension, sepsis, variceal bleeding, respiratory
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failure, acute kidney dysfunction, intestinal per -
foration, and mortality. With a large-for-size graft,
there is low portal blood flow, which impairs hepatic
circulation, as well as size discordance between the
vascular lumens, insufficient blood supply to the
graft, and the insufficient size of the recipient’s
abdominal cavity.5-8 Akdur and colleagues showed
that large-for-size grafts may cause abdo1minal
compartment syndrome and vascular problems as a
result of the relatively small recipient size.2
We conducted this study to raise awareness of the
metabolic and hemodynamic changes associated
with graft-recipient size mismatching. We hypo -
thesize that a high graft weight to recipient body
weight ratio (> 4%) in pediatric liver transplant
adversely affects intraoperative and early post -
operative hemodynamic and metabolic parameters.
Materials and Methods
Patients
In this retrospective study, we reviewed data from
130 pediatric patients who underwent an isolated
liver transplant between 2005 to 2015 at Baskent
University Hospital. Demographic data included
age, sex, and cause of liver disease (viral, biliary,
idiopathic). Child-Pugh and pediatric end-stage liver
disease scores were recorded. The intraoperative and
postoperative inotropic agents that were used,
intraoperative complications, and incidence of
mortality were also noted. 
Donor and grafts 
Grafts were recovered from healthy adult living
donors. The donors included 111 parents (40 fathers
and 71 mothers) and 19 other relatives of the patients. 
Intraoperative and postoperative intensive care
management 
We divided the transplant operation into 2 phases
based on liver function: the anhepatic phase, from
the beginning of the operation to liver activation by
reflow of graft portal vein and hepatic artery; and the
neohepatic phase, from reflow of portal vein and
hepatic artery circulation to the end of the operation.
All patients had a radial arterial catheter in place for
invasive blood pressure monitoring, a femoral
arterial catheter for pulse contour cardiac output
monitoring, and a central venous catheter for fluid
replacement. After induction of anesthesia, patients
received infusions of desflurane, remifentanil,
rocuronium, and norepinephrine. Intraoperative
data, including the use of blood products, urine
output, central venous pressure, body temperature,
systolic-diastolic arterial pressures, pH, PO2, lactate,
potassium, and blood glucose levels, for both the
anhepatic and the hepatic phases were recorded.
Graft size was evaluated by graft-weight-to-
recipient-body-weight ratio (G/R ratio = graft weight
[kg] / recipient body weight [kg]). We assigned
patients into 2 groups based on their G/R ratio:
recipients with a G/R > 4% (large for size) and those
with a G/R ≤ 4% (normal for size).
The immunosuppressive drug regimen consisted
of tacrolimus and steroids. Methylprednisolone 
(10 mg/kg) was administered during the reflow of
graft portal vein and hepatic artery anastomosis.
After transplant, methylprednisolone was started at
a dose of 2 mg/kg per day and was continued for 6
months. Acute rejection was diagnosed when clinical
signs of fever and increased levels of transaminases
and/or bilirubin with or without histologic diagnosis
were observed. A steroid bolus injection was given
with or without a change in tacrolimus dose if acute
rejection occurred.
Statistical analyses
Values are shown as mean plus or minus standard
deviation or as median and range. For statistical
comparison, the Mann-Whitney test for continuous
data and the chi-squared test for categorical data
were used. P values less than .05 were regarded as
statistically significant. 
Results 
Data from 130 pediatric liver transplant recipients
were included in the analyses. There were 61 female
patients (47%) ranging in age from 5 months to 14
years (4.6 ± 3.8 y), and the body weight of all 
patients ranged from 5 to 37 kg (15.7 ± 8.5 kg). Age
(1.0 ± 0.3 y vs 5.5 ± 3.8 y; P < .001) and body weight
(6.8 ± 0.7 kg vs 178 ± 8.1 kg; P < .001) were statistically
significantly different between the 2 groups. Patient
demographics are shown in Table 1. 
Mean Child-Pugh and pediatric end-stage liver
disease scores were 8.7 and 17.1, respectively. Child-
Pugh (9.6 ± 1.3 vs 8.5 ± 2.1; P = .013) and pediatric
end-stage liver disease (27.8 ± 11.3 vs 14.5 ± 15.2; 
P < .001) scores also were significantly different
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between the groups. Patients in the G/R > 4% group
received more colloid solution and higher doses of
furosemide than did patients in the G/R ≤ 4% group.
They also received norepinephrine infusion intra -
operatively more often (44% vs 22%; P < .05) and had
higher blood glucose values (352.8 ± 96.9 mg/dL vs
262.8 ± 88.2 mg/dL; P < .001) than did patients in the
G/R ≤ 4% group (Table 2). 
Patients in the G/R > 4% group received more
packed red blood cell transfusions during both the
anhepatic (30.3 ± 24.3 mL/kg vs 18.8 ± 21.8 mL/kg; 
P = .013) and the neohepatic (17.7 ± 20.4 mL/kg vs 
10.3 ± 15.5 mL/kg; P = .031) phases and more fresh
frozen plasma (13.6 ± 17.6 mL/kg and 6.2 ± 10.2  mL/kg;
P = .012) during the neohepatic phase. During the
anhepatic phase, urinary output was lower in the
G/R > 4% group than in the G/R ≤ 4% group 
(6.3 ± 4.6 mL/kg vs 9.3 ± 6.9 mL/kg; P = .024). The
G/R > 4% group also was more likely to be
hypotensive intraoperatively during all phases 
(P < .05) and to have lower mean pH (7.1 ± 0.1 vs 
7.2 ± 0.1; P = .004) and PO2 (115.4 ± 44.6 mm Hg vs
147.6 ± 49.3 mm Hg; P = .004) values and lower mean
body temperatures (34.8 ± 0.7°C vs 35.2 ± 0.6°C; 
P = .016) during the neohepatic phase (Table 3 and
Table 4).
More patients in the G/R > 4% group were
mechanically ventilated in the intensive care unit
(56% vs 31%, P = .035). There were no significant
differences between the groups in postoperative
acute renal dysfunction, graft rejection or loss,
infections, length of intensive care stay, and mortality
(P > .05) (Table 5).
Discussion 
In this retrospective study, a G/R > 4% was as -
sociated with metabolic and hemodynamic adverse
outcomes in pediatric living-donor liver transplant
recipients. Recipients with a large-for-size graft were
more likely to be hypotensive and hypothermic and
to need greater amounts of colloid fluid replace -
ments, blood product transfusions, and norepine -
phrine intraoperatively. More patients in this group
were mechanically ventilated postoperatively.
Whereas the small-for-size syndrome is asso -
ciated with poor graft survival, inferior outcome, and
significant mortality compared to a normal-for-size
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Table 1. Patient Demographics (N = 130)
Value†
Age (y) 4.6 ± 3.8
Sex (female) 61 (47)
Weight (kg) 15.7 ± 8.5
Child-Pugh score 8.7 ± 2.0
PELD score 17.1 ± 15.4
Abbreviations: PELD, pediatric end-stage liver disease
†Data are mean ± standard deviation or number (%).
Table 2. Comparison of Demographics, Scores, and Intraoperative
Parameters
Parameter G/R ≤ 4%* G/R > 4%* P Value
Age (y) 5.5 ± 3.8 1.0 ± 0.3 < .001
Sex (female) 51 (49) 10 (40) .508
Weight (kg) 17.8 ± 8.1 6.8 ± 0.7 < .001
Child-Pugh score 8.5 ± 2.1 9.6 ± 1.3 .013
PELD score 15. ± 15.2 27.8 ± 11.3 < .001
Colloid (mL/kg) 45.1 ± 21.9 57.7 ± 20.1 .008
Furosemide (mg/kg) 0.4 ± 0.7 0.7 ± 0.6 .018
Norepinephrine 23 (22) 11 (44) .040
Blood glucose (mg/dL) 262.8 ± 88.2 352.8 ± 96.9 < .001
Abbreviations: G/R, graft-weight-to-recipient-body-weight; PELD, pediatric
end-stage liver disease
*Data are mean ± standard deviation or number (%).
Table 3. Comparison of Intraoperative Parameters During Anhepatic Phase
Parameter G/R ≤ 4%* G/R > 4%* P Value
PRBC transfusion (mL/kg) 18.8 ± 21.8 30.3 ± 24.3 .013
FFP transfusion (mL/kg) 15.5 ± 16.0 26.4 ± 28.6 .130
Urinary output (mL/kg) 9.3 ± 6.9 6.3 ± 4.6 .024
pH 7.3 ± 0.1 7.3 ± 0.1 .474
Blood pressure (mm Hg)
Systolic 67.0 ± 13.9 63.3 ± 12.8 .143
Diastolic 35.4 ± 8.6 31.5 ± 8.5 .026
PO2 (mm Hg) 151.7 ± 52.9 124.5 ± 51.3 .021
Body temperature (°C) 35.4 ± 0.8 35.1 ± 0.6 .082
Abbreviations: FFP, fresh frozen plasma; G/R, graft-weight-to-recipient-
body-weight; pH, power of hydrogen; PO2, partial pressure of oxygen;
PRBC, packed red blood cells 
aData are mean ± standard deviation.
Table 4. Comparison of Intraoperative Parameters During Neohepatic
Phase
Parameter G/R ≤ 4%* G/R > 4%* P Value
PRBC transfusion (mL/kg) 10.3 ± 15.5 17.7 ± 20.4 .031
FFP transfusion (mL/kg) 6.2 ± 10.2 13.6 ± 17.6 .012
Urinary output (mL/kg) 9.9 ± 9.2 10.3±12.2 .688
pH 7.2 ± 0.1 7.2 ± 0.1 .045
Blood pressure (mm Hg)
Systolic 77.9 ± 19.3 61.5 ± 20.0 .001
Diastolic 36.2 ± 11.1 30.6 ± 8.5 .009
PO2 (mm Hg) 200.1 ± 71.7 172.3 ± 44.0 .141
Body temperature (°C) 35.2 ± 0.6 34.8 ± 0.7 .016
Abbreviations: FFP, fresh frozen plasma; G/R, graft-weight-to-recipient-
body-weight; pH, power of hydrogen; PO2, artial pressure of oxygen; PRBC,
packed red blood cells
*Data are mean ± standard deviation.
Table 5. Comparison of Postoperative Parameters 
Parameter G/R ≤ 4%* G/R > 4%* P Value
Mechanical ventilation 33 (31) 14 (56) .035
Tracheostomy 6 (6) 0 (0) .595
Revision surgery 35 (34) 10 (40) .641
Acute kidney injury 13 (13) 0 (0) .127
Graft rejection 16 (16) 2 (8) .523
Graft loss 9 (9) 0 (0) .204
Mortality 13 (13) 2 (8) .734
Abbreviations: G/R, graft-weight-to-recipient-body-weight 
*Data are number (%).
liver transplant,4,5 there are also serious adverse
outcomes related to a large-for-size graft, including
increased intra-abdominal and intrathoracic pres -
sures, atelectasis formation, prolonged intubation,
decreased cardiac output, hypotension, and kidney
and graft injury related to decreased perfusion. In
addition, the need for high levels of antigen in large-
for-size grafts is associated with a high incidence of
rejection.4,6
Consistent with these findings, in our study,
intraoperative hypotension was observed more
frequently in patients with a G/R > 4%. Because the
large graft receives relatively low portal blood flow
due to the small recipient size, impairment in hepatic
microcirculation may occur. Furthermore, external
compression due to the small abdominal cavity also
may lead to hepatic hypoperfusion. This hypo -
perfusion leads to prolonged warm ischemia time.
Release of inflammatory mediators by the ischemic
tissue and distribution of volume into the graft 
may explain this hemodynamic instability.4 This
mechanism may also explain the greater need for
colloid fluids and furosemide administration in these
patients.
In a retrospective study by Levesque and
colleagues, more pediatric and adult liver transplant
recipients in the higher G/R group developed
respiratory failure compared with patients in the
normal-for-size group.7 In our study, more patients
in the large-for-size group were mechanically
ventilated postoperatively. This finding may be
explained by an increase in intra-abdominal and
intrathoracic pressures, atelectasis, and respiratory
failure.4 In addition, the large-for-size group in our
study received more blood product transfusions.
This finding may be explained by hypotension due to
external compression of the venous system and
distribution of volume into the graft. This greater
need for blood product transfusions may lead to a
higher rate of respiratory failure and the need for
mechanical ventilation postoperatively. It also may
be the reason these patients were more hypothermic.
The superior results with normal-sized grafts may be
attributable to vascular factors. Akdur and col -
leagues reported vascular kinking with large grafts
that required treatment with the Bogota bag
technique.2
Living-donor liver transplant remains the
treatment option for liver failure for many patients
owing to the shortage of deceased-donor organ
donation in our country. Success of the transplant
surgery largely depends on matching the graft size
to the recipient’s body weight. The G/R ratio is used
to determine the minimum graft volume in living-
donor liver transplant.4
Conclusions
The importance of the appropriate relation between
graft size and recipient body weight in liver
transplant is becoming more apparent. The use of
indexes such as the G/R ratio make it possible to
transplant an appropriately sized graft and thereby
to reduce postoperative adverse outcomes and
improve survival. While the outcomes with small-
for-size grafts are now well established, the effects of
large-for-size grafts in pediatric living-donor liver
transplant need to be studied further.
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